7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Neoplasms, Squamous Cell D018307 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Dentin Dysplasia D003805 1 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Prediabetic State D011236 1 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Rheumatic Fever D012213 1 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Neoplastic Syndromes, Hereditary D009386 1 associated lipids
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Dental Pulp Exposure D003789 1 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Hemarthrosis D006395 1 associated lipids
Cherubism D002636 1 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Mandibular Injuries D008338 1 associated lipids
Diabetic Foot D017719 1 associated lipids
Emphysema D004646 1 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Spondylarthropathies D025242 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Ankylosis D000844 1 associated lipids
Jaw, Edentulous D007575 1 associated lipids
Foot Injuries D018409 1 associated lipids
Synovitis, Pigmented Villonodular D013586 1 associated lipids
Periostitis D010522 1 associated lipids
Prosthesis Failure D011475 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Osteopetrosis D010022 1 associated lipids
Histiocytosis, Langerhans-Cell D006646 1 associated lipids
Jaw, Edentulous, Partially D007576 1 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angioid Streaks D000793 1 associated lipids
Atrial Remodeling D064752 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Tooth Resorption D014091 1 associated lipids
Hyperostosis D015576 1 associated lipids
Hip Dislocation D006617 1 associated lipids
Rupture, Spontaneous D012422 1 associated lipids
Malocclusion, Angle Class I D008311 1 associated lipids
Peri-Implantitis D057873 1 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Hashimoto Disease D050031 1 associated lipids
Legg-Calve-Perthes Disease D007873 1 associated lipids
Fluorosis, Dental D009050 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
POEMS Syndrome D016878 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Osteolysis, Essential D010015 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Actinomycosis D000196 2 associated lipids
Fractures, Stress D015775 2 associated lipids
Osteosclerosis D010026 2 associated lipids
Osteophyte D054850 2 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Pericardial Effusion D010490 2 associated lipids
Lymphocytosis D008218 2 associated lipids
Prenatal Exposure Delayed Effects D011297 2 associated lipids
Radicular Cyst D011842 2 associated lipids
Gingival Recession D005889 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Foot Deformities, Acquired D005531 2 associated lipids
Tooth Migration D014085 2 associated lipids
Dengue D003715 2 associated lipids
Musculoskeletal Diseases D009140 2 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Ossification, Heterotopic D009999 2 associated lipids
Hip Fractures D006620 2 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Angina, Stable D060050 2 associated lipids
Sarcoma, Ewing D012512 2 associated lipids
Urologic Neoplasms D014571 2 associated lipids
Tooth Mobility D014086 2 associated lipids
Otosclerosis D010040 2 associated lipids
Root Resorption D012391 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Microvascular Angina D017566 2 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Dermatomyositis D003882 2 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Eye Neoplasms D005134 2 associated lipids
Lithiasis D020347 2 associated lipids
Labyrinthitis D007762 2 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Nakamura M et al. [Cytokine-mediated bone resorption]. 2014 Clin Calcium pmid:24870834
Hong YY et al. Fibroblasts regulate variable aggressiveness of syndromic keratocystic and non-syndromic odontogenic tumors. 2014 J. Dent. Res. pmid:24972872
Brabnikova-Maresova K et al. Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis. 2014 Arthritis Res. Ther. pmid:25280749
Tao K et al. Influences of IL-6R antibody on PMMA bone cement-mediated expression of OPG and RANKL in synovial fibroblasts. 2014 J. Huazhong Univ. Sci. Technol. Med. Sci. pmid:24710939
Lis GJ et al. Elevated serum osteoprotegerin is associated with decreased osteoclastic differentiation in stenotic aortic valves. 2014 J. Physiol. Pharmacol. pmid:24930509
Rody WJ et al. Differences in the gingival crevicular fluid composition between adults and adolescents undergoing orthodontic treatment. 2014 Angle Orthod pmid:23687969
Scialla JJ et al. Biomarkers of vascular calcification and mortality in patients with ESRD. 2014 Clin J Am Soc Nephrol pmid:24458076
Ohba T et al. Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. 2014 J. Bone Miner. Res. pmid:24443409
Marques EA et al. Response of bone mineral density, inflammatory cytokines, and biochemical bone markers to a 32-week combined loading exercise programme in older men and women. 2013 Sep-Oct Arch Gerontol Geriatr pmid:23623588
Liu S et al. Association between g.19163A>G and g.23298T>C genetic variants of the osteoprotegerin gene and bone mineral density in Chinese women. 2013 Oct-Dec Hormones (Athens) pmid:24457406
Chiang PH et al. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan. 2013 Oct-Dec J Cancer Res Ther pmid:24518712
Canto-Cetina T et al. Polymorphism of LRP5, but not of TNFRSF11B, is associated with a decrease in bone mineral density in postmenopausal Maya-Mestizo women. 2013 Nov-Dec Am. J. Hum. Biol. pmid:24130145
Horshuns'ka MIu et al. [Biological role of fetuin A and its potential importance for prediction of cardiovascular risk in patients with type 2 diabetes mellitus]. 2013 May-Jun Ukr Biokhim Zh (1999) pmid:23937044
Zamora PO et al. Biocompatibility and inflammation profile of B2A-coated granules used in arthrodesis. 2013 Mar-Apr Int. J. Toxicol. pmid:23422080
Esteghamati A et al. Comparison of osteoprotegerin and vascular endothelial growth factor in normoalbuminuric Type 1 diabetic and control subjects. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23877020
Glintborg D et al. Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome. 2013 Jul-Aug J. Endocrinol. Invest. pmid:23211475
Nanjundaiah SM et al. Kinetics and interplay of mediators of inflammation-induced bone damage in the course of adjuvant arthritis. 2013 Jan-Mar Int J Immunopathol Pharmacol pmid:23527707
Guzel S et al. Osteoprotegerin, leptin and IL-6: association with silent myocardial ischemia in type 2 diabetes mellitus. 2013 Diab Vasc Dis Res pmid:22496403
Danks L and Takayanagi H Immunology and bone. 2013 J. Biochem. pmid:23750028
Tao H et al. OPG/RANK/RANKL axis as a potential therapeutic target for atrial fibrillation. 2013 Cardiology pmid:23751957
Xi L et al. OPG/RANK/RANKL axis in atrial fibrillation. 2013 Cardiology pmid:23752030
Ostrowska Z et al. Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. 2013 Postepy Hig Med Dosw (Online) pmid:23752595
Uehara H et al. Induction of retinol-binding protein 4 and placenta-specific 8 expression in human prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by osteoprotegerin. 2013 Int. J. Oncol. pmid:23708710
Luo J et al. 1,25-dihydroxyvitamin D3 inhibits the RANKL pathway and impacts on the production of pathway-associated cytokines in early rheumatoid arthritis. 2013 Biomed Res Int pmid:23710436
Zhu Y et al. Deciduous dental pulp stem cells are involved in osteoclastogenesis during physiologic root resorption. 2013 J. Cell. Physiol. pmid:22674471
Neunaber C et al. Differentiation of osteoprogenitor cells is affected by trauma-haemorrhage. 2013 Injury pmid:23773407
Hakimi M et al. The expression of glycophorin A and osteoprotegerin is locally increased in carotid atherosclerotic lesions of symptomatic compared to asymptomatic patients. 2013 Int. J. Mol. Med. pmid:23722820
Van Schepdael A et al. A mechanobiological model of orthodontic tooth movement. 2013 Biomech Model Mechanobiol pmid:22539046
Ai LS et al. Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo. 2013 Int. J. Cancer pmid:23420490
Koide M et al. Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice. 2013 Endocrinology pmid:23291450
Pacifici R Osteoimmunology and its implications for transplantation. 2013 Am. J. Transplant. pmid:23915249
Albu A et al. Bone metabolism regulators and arterial stiffness in postmenopausal women. 2013 Maturitas pmid:23916080
Panzarini SR et al. Histological and immunohistochemical analyses of the chronology of healing process after immediate tooth replantation in incisor rat teeth. 2013 Dent Traumatol pmid:22413942
Bauer S et al. Early detection of bone metabolism changes under different antiepileptic drugs (ED-BoM-AED)--a prospective multicenter study. 2013 Epilepsy Res. pmid:23916144
Nile CJ et al. Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease. 2013 J. Clin. Periodontol. pmid:23919740
Kim HR et al. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. 2013 Nephron Clin Pract pmid:23921088
O'Sullivan EP et al. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance. 2013 Metab. Clin. Exp. pmid:22841521
Steensma MR et al. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy. 2013 PLoS ONE pmid:23922683
Mazière C et al. Oxidized low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress. 2013 Biochem. Biophys. Res. Commun. pmid:24070606
He JY et al. Sympathetic neuron can promote osteoblast differentiation through BMP signaling pathway. 2013 Cell. Signal. pmid:23454096
Benito-Martin A et al. Osteoprotegerin in exosome-like vesicles from human cultured tubular cells and urine. 2013 PLoS ONE pmid:24058411
Yu J et al. Effect of fluoride and low versus high levels of dietary calcium on mRNA expression of osteoprotegerin and osteoprotegerin ligand in the bone of rats. 2013 Biol Trace Elem Res pmid:23456427
Lau CP et al. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone. 2013 Connect. Tissue Res. pmid:24060052
Corrado A et al. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects. 2013 J. Rheumatol. pmid:23457386
Koluman BU et al. Association between osteoprotegerin, fetuin-A, carotid intima media thickness, and urinary albumin excretion in Type 2 diabetes. 2013 Clin. Nephrol. pmid:23458176
Wang J et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system. 2013 Med. Hypotheses pmid:24074896
Kuo PL et al. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. 2013 Biochim. Biophys. Acta pmid:23458685
Li F et al. Effect of parathyroid hormone on experimental tooth movement in rats. 2013 Am J Orthod Dentofacial Orthop pmid:24075660
Asanuma YF et al. Serum osteoprotegerin concentration is associated with carotid atherosclerotic plaque in patients with rheumatoid arthritis. 2013 Mod Rheumatol pmid:22584471
Sato K et al. RANKL synthesized by both stromal cells and cancer cells plays a crucial role in osteoclastic bone resorption induced by oral cancer. 2013 Am. J. Pathol. pmid:23499553
Pneumaticos SG et al. Osteoprotegerin expression during the micro- and macrometastatic phases of the osteoblastic metastasis in prostate cancer: therapeutic implications. 2013 Expert Opin. Ther. Targets pmid:24024908
Sooampon S et al. Transient receptor potential vanilloid-1 regulates osteoprotegerin/RANKL homeostasis in human periodontal ligament cells. 2013 J. Periodont. Res. pmid:22587561
Matuszewski Ł et al. Effect of implanted bisphosphonate-enriched cement on the trabecular microarchitecture of bone in a rat model using micro-computed tomography. 2013 Int Orthop pmid:23503639
Galli C et al. GSK3b-inhibitor lithium chloride enhances activation of Wnt canonical signaling and osteoblast differentiation on hydrophilic titanium surfaces. 2013 Clin Oral Implants Res pmid:22626030
Albers J et al. Canonical Wnt signaling inhibits osteoclastogenesis independent of osteoprotegerin. 2013 J. Cell Biol. pmid:23401003
Baud'huin M et al. Osteoprotegerin: multiple partners for multiple functions. 2013 Cytokine Growth Factor Rev. pmid:23827649
Wang Q et al. The relationship between osteoprotegerin gene polymorphisms and bone mineral density in Chinese postmenopausal women. 2013 Int. Immunopharmacol. pmid:23856613
Mogi M and Kondo A The presence of RANKL-OPG complex in human osteosarcoma U2OS. 2013 J Immunoassay Immunochem pmid:23859786
Zappitelli T et al. The G60S connexin 43 mutation activates the osteoblast lineage and results in a resorption-stimulating bone matrix and abrogation of old-age-related bone loss. 2013 J. Bone Miner. Res. pmid:23606335
Kao SY et al. Loss of osteoprotegerin expression in the inner ear causes degeneration of the cochlear nerve and sensorineural hearing loss. 2013 Neurobiol. Dis. pmid:23607938
Wu M et al. Vascular calcification: an update on mechanisms and challenges in treatment. 2013 Calcif. Tissue Int. pmid:23456027
Venojärvi M et al. 12 weeks' aerobic and resistance training without dietary intervention did not influence oxidative stress but aerobic training decreased atherogenic index in middle-aged men with impaired glucose regulation. 2013 Food Chem. Toxicol. pmid:23623841
Kitamura K et al. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. 2013 Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. pmid:23632157
Shen L et al. Association between osteoprotegerin genetic variants and bone mineral density in Chinese women. 2013 Int. Immunopharmacol. pmid:23619553
Zhou J et al. [Effect of sinusoidal electromagnetic fields on rats femur tissue cultivation in vitro]. 2013 Sheng Wu Yi Xue Gong Cheng Xue Za Zhi pmid:23865319
Gao L et al. Resolvin E1 and chemokine-like receptor 1 mediate bone preservation. 2013 J. Immunol. pmid:23241890
Brabnikova Maresova K et al. Acute effects of glucocorticoids on serum markers of osteoclasts, osteoblasts, and osteocytes. 2013 Calcif. Tissue Int. pmid:23247536
Eren MA et al. Association of parity with osteoprotegerin levels and atherosclerosis. 2013 Arch. Gynecol. Obstet. pmid:23287888
Kim SJ et al. Compressive stress induced the up-regulation of M-CSF, RANKL, TNF-α expression and the down-regulation of OPG expression in PDL cells via the integrin-FAK pathway. 2013 Arch. Oral Biol. pmid:23219295
Kanzaki H et al. Mutations in K-Ras linked to levels of osteoprotegerin and sensitivity to TRAIL-induced cell death in pancreatic ductal adenocarcinoma cells. 2013 Exp. Mol. Pathol. pmid:23219833
Wang H et al. Combination gene therapy targeting on interleukin-1β and RANKL for wear debris-induced aseptic loosening. 2013 Gene Ther. pmid:22318091
Hussien YM et al. Polymorphism in vitamin D receptor and osteoprotegerin genes in Egyptian rheumatoid arthritis patients with and without osteoporosis. 2013 Mol. Biol. Rep. pmid:23271131
Ko GJ A biomarker, osteoprotegerin, in patients undergoing hemodialysis. 2013 Korean J. Intern. Med. pmid:24307839
Lee JE et al. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. 2013 Korean J. Intern. Med. pmid:24307842
Hartwich JE et al. Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model. 2013 J. Pediatr. Surg. pmid:23331792
Naidu VG et al. RANKL targeted peptides inhibit osteoclastogenesis and attenuate adjuvant induced arthritis by inhibiting NF-κB activation and down regulating inflammatory cytokines. 2013 Chem. Biol. Interact. pmid:23333834
Zhang Q et al. Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis. 2013 ScientificWorldJournal pmid:24222748
Yao Y et al. Combination of MTX and LEF attenuates inflammatory bone erosion by down-regulation of receptor activator of NF-kB ligand and interleukin-17 in type II collagen-induced arthritis rats. 2013 Rheumatol. Int. pmid:23334376
Luo ZR et al. [A study of relationship between dialectical classification according to traditional Chinese medicine of acute coronary syndrome with serum osteoprotegerin and its ligand]. 2013 Zhonghua Wei Zhong Bing Ji Jiu Yi Xue pmid:24225213
Zhang F et al. Association analyses of osteoprotegerin gene polymorphisms with bone mineral density in Chinese postmenopausal women. 2013 Med. Oncol. pmid:23335067
Tisato V et al. GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients. 2013 Mediators Inflamm. pmid:24327798
Su SJ et al. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line. 2013 Int J Food Sci Nutr pmid:23301724
Aoki A et al. Association of serum osteoprotegerin with vascular calcification in patients with type 2 diabetes. 2013 Cardiovasc Diabetol pmid:23302066
Pathan E et al. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in ankylosing spondylitis. 2013 Ann. Rheum. Dis. pmid:22984171
Guerra-Menéndez L et al. IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand. 2013 J Transl Med pmid:24161214
MacNee W Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease. 2013 Ann. Med. pmid:23110517
Montagnana M et al. The role of osteoprotegerin in cardiovascular disease. 2013 Ann. Med. pmid:23110639
Romagnoli C et al. Role of GSH/GSSG redox couple in osteogenic activity and osteoclastogenic markers of human osteoblast-like SaOS-2 cells. 2013 FEBS J. pmid:23176170
Revu S et al. Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. 2013 Arthritis Res. Ther. pmid:24295447
Kadkhodazadeh M et al. Analysis of RANKL gene polymorphism (rs9533156 and rs2277438) in Iranian patients with chronic periodontitis and periimplantitis. 2013 Arch. Oral Biol. pmid:23177932
Gutiérrez-Rojas I et al. Amylin exerts osteogenic actions with different efficacy depending on the diabetic status. 2013 Mol. Cell. Endocrinol. pmid:23178165
Barbieri G et al. Biochemical markers of bone metabolism in gingival crevicular fluid during early orthodontic tooth movement. 2013 Angle Orthod pmid:22716279
Bolzoni M et al. Immunomodulatory drugs lenalidomide and pomalidomide inhibit multiple myeloma-induced osteoclast formation and the RANKL/OPG ratio in the myeloma microenvironment targeting the expression of adhesion molecules. 2013 Exp. Hematol. pmid:23178378
Lee MH et al. The effect of surface microgrooves and anodic oxidation on the surface characteristics of titanium and the osteogenic activity of human periodontal ligament cells. 2013 Arch. Oral Biol. pmid:22717323
Dalcico R et al. Protective mechanisms of simvastatin in experimental periodontal disease. 2013 J. Periodontol. pmid:23181416
Mercatali L et al. RANK/RANK-L/OPG in patients with bone metastases treated with anticancer agents and zoledronic acid: a prospective study. 2013 Int J Mol Sci pmid:23702841
Braun T et al. Mitogen-activated protein kinase 2 regulates physiological and pathological bone turnover. 2013 J. Bone Miner. Res. pmid:23169443
Tousoulis D et al. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease. 2013 Int. J. Cardiol. pmid:22640692
Rivadeneira F Hunting osteoporosis susceptibility genes: bigger is better but diverse is also welcome. 2013 Endocrine pmid:23001603
Scott JP et al. Effect of recovery duration between two bouts of running on bone metabolism. 2013 Med Sci Sports Exerc pmid:23034642

Table of Content